AR, B., C, M., M, L., JN, G., AJ, Y., E, O., . . . SR, S. (2025). Prospective study of immunogenicity to SARS-CoV-2 booster vaccines in multiple myeloma and Waldenström macroglobulinemia. Blood advances, 9(18), 4568. https://doi.org/10.1182/bloodadvances.2025016513
Chicago Style (17th ed.) CitationAR, Branagan, et al. "Prospective Study of Immunogenicity to SARS-CoV-2 Booster Vaccines in Multiple Myeloma and Waldenström Macroglobulinemia." Blood Advances 9, no. 18 (2025): 4568. https://doi.org/10.1182/bloodadvances.2025016513.
MLA (9th ed.) CitationAR, Branagan, et al. "Prospective Study of Immunogenicity to SARS-CoV-2 Booster Vaccines in Multiple Myeloma and Waldenström Macroglobulinemia." Blood Advances, vol. 9, no. 18, 2025, p. 4568, https://doi.org/10.1182/bloodadvances.2025016513.